Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TDO2 | P48775 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | CCR3 | P51677 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2775348 | 1.00 | CYP1A2 (0.46) | CYP1A2CYP2A6TDO2BACE1AHR | |
| SCHEMBL18733501 | 0.92 | CYP1A2 (0.46) | CYP1A2CYP2A6TDO2BACE1AHR | |
| SCHEMBL31556379 | 0.75 | CYP2A6 (0.46) | CYP1A2CYP2A6BACE1AHRL3MBTL1 | |
| SCHEMBL1536308 | 0.75 | CYP2A6 (0.46) | CYP1A2CYP2A6BACE1AHRL3MBTL1 | |
| SCHEMBL16637560 | 0.75 | CYP2A6 (0.46) | CYP2A6AHR | |
| SCHEMBL3698199 | 0.75 | CYP1A2 (0.54) | CYP1A2CYP2A6BACE1 | |
| SCHEMBL6562601 | 0.74 | CYP1A2 (0.77) | CYP1A2CYP2A6BACE1AHRL3MBTL1 | |
| SCHEMBL30366405 | 0.74 | CYP1A2 (0.77) | CYP1A2CYP2A6BACE1AHRL3MBTL1 | |
| SCHEMBL1412043 | 0.73 | CYP2A6 (0.52) | CYP1A2CYP2A6L3MBTL1ACHE | |
| Hydrochloric Acid SCHEMBL6435272 | 0.73 | CYP2A6 (0.45) | CYP2A6BACE1AHRL3MBTL1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024226875-A2 | COMPOUNDS, COMPOSITIONS AND METHODS FOR ATTENUATION OF MAMMALIAN TRANSLATION OF C-MYC OR N-MYC PROTEINS OF THE MYC PROTO-ONCOGENE FAMILY OF BHLH TRANSCRIPTION FACTORS | INITIAL THERAPEUTICS, INC. (US) | 2024-10-31 | — | — | WO | disclosed |